Results 1 to 10 of about 6,565 (207)

HbA1c variability in adults with type 1 diabetes on continuous subcutaneous insulin infusion (CSII) therapy compared to multiple daily injection (MDI) treatment [PDF]

BMJ Open, 2019
Objective To determine if continuous subcutaneous insulin infusion (CSII) therapy is associated with lower glycatedhaemoglobin (HbA1c) variability (long-term glycaemic variability; GV) relative to multiple daily injection (MDI) treatment in adults with ...
Emma S Scott, Rachel T McGrath, Andrzej S Januszewski, Daniel Calandro, Anandwardhan A Hardikar, David N O'Neal, Gregory Fulcher, Alicia J Jenkins   +7 more
doaj   +4 more sources

Recurrent diabetic ketoacidosis burden and precipitant patterns in established type 1 diabetes using continuous subcutaneous insulin infusion versus multiple daily injections: an 11-year retrospective single-center study [PDF]

BMC Endocrine Disorders
Background Diabetic ketoacidosis (DKA) remains a major acute complication in people with established type 1 diabetes, but whether recurrent DKA burden and precipitant patterns differ by insulin-delivery modality is not well defined. We compared recurrent
Ruixia Liu, Tianrong Pan
doaj   +2 more sources

Effects of Short‐Term Intensive Insulin Therapy Combined With Oral Hypoglycemic Agents for Inducing Remission in Newly Diagnosed Type 2 Diabetes Mellitus: A Randomized Clinical Trial [PDF]

Journal of Diabetes
Aims To investigate the effects of combining oral hypoglycemic agents with short‐term intensive insulin therapy (SIIT) via continuous subcutaneous insulin infusion (CSII) on glycemic outcomes in adults with newly diagnosed type 2 diabetes mellitus ...
Weijian Ke, Liehua Liu, Pengyuan Zhang, Li Yan, Qian Zhang, Fan Zhang, Xuejuan Xu, Juan Liu, Lijuan Xu, Xuesi Wan, Hai Li, Xiaopei Cao, Haipeng Xiao, Melissa S. Putman, Yanbing Li   +14 more
doaj   +2 more sources

Strategies to optimize glucose control during exercise in subjects with type 1 diabetes [PDF]

CellR4, 2020
Regular physical activity is highly recommended in subjects with type 1 diabetes (T1D) because of its beneficial impact on body composition, cardiovascular disease risk profile, glucose control and psychological wellbeing.
F. Silvestri, F. Costantino, V. Tromba
doaj   +1 more source

Tham gia TPP: cơ hội và thách thức đối với ngành dệt may Việt Nam

Tạp chí Khoa học Đại học Đồng Tháp, 2023
Theo đánh giá của các chuyên gia kinh tế, Hiệp định Đối tác xuyên Thái Bình Dương (TPP) có thể tạo ra sự thay đổi lớn trong thương mại dệt may toàn cầu và Việt Nam đang đặt rất nhiều kỳ vọng ở thị trường rộng lớn này, đặc biệt là thị trường Mỹ.
That Vien Ton
doaj   +1 more source

Metabolic control and hypoglycaemia in people with type 1 diabetes: insulin pump therapy vs. intensified insulin therapy in an unselected cohort in routine care

Diabetology & Metabolic Syndrome, 2021
Aims The aim of this study was to compare individuals with type 1 diabetes with continuous subcutaneous insulin infusion (CSII) and intensified insulin therapy (ICT) in routine care regarding metabolic control and treatment satisfaction.
Guido Kramer, Christof Kloos, Ulrich A. Müller, Gunter Wolf, Nadine Kuniss   +4 more
doaj   +1 more source

Long-term glycemic control and factors, associated with response to pump insulin therapy in children

Сахарный диабет, 2021
Background: In recent years, pump-based insulin therapy, also known as continuous subcutaneous insulin infusion (CSII), has become a common treatment for children with type 1 diabetes mellitus (T1DM). Despite the fact that, in general, children with type
D. N. Laptev, A. O. Emelyanov, E D Medvedeva, S. V. Pereverzeva, V. A. Peterkova   +4 more
doaj   +1 more source

Insulin Requirements in Relation to Insulin Pump Indications in Type 1 Diabetes

Notulae Scientia Biologicae, 2015
The purpose of the current research was to assess changes in daily insulin requirements in type 1 diabetic patients transitioning from multiple daily injections (MDI) of insulin to continuous subcutaneous insulin infusion (CSII) using an external insulin
Gabriela GHIMPEŢEANU, Silvia Ş. IANCU, Gabriela ROMAN, Anca M. ALIONESCU   +3 more
doaj   +3 more sources

Predicting basal insulin rates on insulin pumps in Indian patients with type 1 diabetes: The rule of 5

Apollo Medicine, 2021
Aims: To guide diabetes practitioners on setting up of basal rates in patients initiated on continuous subcutaneous insulin pump therapy (CSII) in India.
Krishnan Swaminathan
doaj   +1 more source

Low uptake of continuous subcutaneous insulin infusion therapy in people with type 1 diabetes in Ireland: a retrospective cross-sectional study

BMC Endocrine Disorders, 2020
Background The uptake of continuous subcutaneous insulin infusion (CSII) therapy in those with type 1 diabetes varies internationally and is mainly determined by the national healthcare reimbursement systems. The aim of this study is to estimate national
Katarzyna Anna Gajewska, Kathleen Bennett, Regien Biesma, Seamus Sreenan   +3 more
doaj   +1 more source